370 related articles for article (PubMed ID: 25924572)
21. Ozonolysis applications in drug synthesis.
Van Ornum SG; Champeau RM; Pariza R
Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
[No Abstract] [Full Text] [Related]
22. Preface: Additive manufacturing in pharmaceutical product design.
Rantanen J; Fatouros DG
Adv Drug Deliv Rev; 2021 Nov; 178():113991. PubMed ID: 34582829
[No Abstract] [Full Text] [Related]
23. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
LaPorte TL; Wang C
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
[TBL] [Abstract][Full Text] [Related]
24. Application of mid-IR spectroscopy for the characterization of pharmaceutical systems.
Van Eerdenbrugh B; Taylor LS
Int J Pharm; 2011 Sep; 417(1-2):3-16. PubMed ID: 21167267
[TBL] [Abstract][Full Text] [Related]
25. Crystal polymorphism in chemical process development.
Lee AY; Erdemir D; Myerson AS
Annu Rev Chem Biomol Eng; 2011; 2():259-80. PubMed ID: 22432619
[TBL] [Abstract][Full Text] [Related]
26. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W
Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307
[No Abstract] [Full Text] [Related]
27. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.
Gordon EM; Barrett RW; Dower WJ; Fodor SP; Gallop MA
J Med Chem; 1994 May; 37(10):1385-401. PubMed ID: 8182695
[No Abstract] [Full Text] [Related]
28. Global medicinal chemistry and GPCR conference: interview with Stevan Djuric.
Djuric S
Future Med Chem; 2018 Apr; 10(8):837-838. PubMed ID: 29580099
[TBL] [Abstract][Full Text] [Related]
29. Solid form screening--a review.
Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
[TBL] [Abstract][Full Text] [Related]
30. Impact of surface tension in pharmaceutical sciences.
Fathi Azarbayjani A; Jouyban A; Chan SY
J Pharm Pharm Sci; 2009; 12(2):218-28. PubMed ID: 19732499
[TBL] [Abstract][Full Text] [Related]
31. Lead-oriented synthesis: a new opportunity for synthetic chemistry.
Nadin A; Hattotuwagama C; Churcher I
Angew Chem Int Ed Engl; 2012 Jan; 51(5):1114-22. PubMed ID: 22271624
[TBL] [Abstract][Full Text] [Related]
32. The impact of parallel chemistry in drug discovery.
Edwards PJ
IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
[TBL] [Abstract][Full Text] [Related]
33. Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.
Zarins-Tutt JS; Abraham ER; Bailey CS; Goss RJ
Prog Mol Subcell Biol; 2017; 55():159-186. PubMed ID: 28238038
[TBL] [Abstract][Full Text] [Related]
34. Are pharmaceutics really going supercritical?
Pasquali I; Bettini R
Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
[TBL] [Abstract][Full Text] [Related]
35. Sustainable Practices in Medicinal Chemistry Part 2: Green by Design.
Aliagas I; Berger R; Goldberg K; Nishimura RT; Reilly J; Richardson P; Richter D; Sherer EC; Sparling BA; Bryan MC
J Med Chem; 2017 Jul; 60(14):5955-5968. PubMed ID: 28375009
[TBL] [Abstract][Full Text] [Related]
36. How well do medicinal chemists learn from experience?
Cheshire DR
Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
[TBL] [Abstract][Full Text] [Related]
37. RASA: a rapid retrosynthesis-based scoring method for the assessment of synthetic accessibility of drug-like molecules.
Huang Q; Li LL; Yang SY
J Chem Inf Model; 2011 Oct; 51(10):2768-77. PubMed ID: 21932860
[TBL] [Abstract][Full Text] [Related]
38. Process chemistry: The science, business, logic, and logistics.
Zhang TY
Chem Rev; 2006 Jul; 106(7):2583-95. PubMed ID: 16836293
[No Abstract] [Full Text] [Related]
39. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
40. Drug industry looks to the lab instead of rainforest and reef.
Service RF
Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
